Researchs
-
Long-term, open-label (dose-blinded), extension study ofeptinezumab in children and adolescents with chronic or episodicmigraine
-
Interventional, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of IVeptinezumab in adolescents
-
An open-label study for participants who are non-responders at the end of treatment assessment on the VRDN-001-101 and VRDN-001-301 pivotal studies
-
A randomized, double-masked, placebo-controlled safety, tolerability and efficacy study of VRDN-001
-
A multiple ascending dose (MAD) safety, tolerability & efficacy study of VRDN-001, a humanized monoclonal antibody directed against the IGF-1 receptor, in subjects with thyroid eye disease (TED)
-
A Multicenter Phase 2b Randomized, Double-Masked, Placebo-Controlled Dose-Ranging Study of TOUR006 in Participants with Thyroid Eye Disease
-
Cannabis use frequency and its impact on monocyte-mediated inflammation in HIV patients
-
Research Supplements to Promote Diversity in Health-Related Research: NIH - R01 Diversity Supplement (GM134307)
-
Imaging cerebral waste clearance responses during exosome treatment of diabetes
-
Mekong One Health Innovation Program (MOHIP)
-
Environmental Justice and Public Health: Climate, Land, & (Health) Outcome of Dengue Fever (CLOUD)
-
Treating Chronic Cervicogenic Head And Neck Pain With Osteopathic Manipulation And Exercise Therapy
-
Response of HIV Patients to the COVID-19 vaccine and Natural COVID-19 Infection
-
TOPAZ: Trial of Parkinson's and Zoledronic Acid. A Randomized Placebo-controlled Trial of Zoledronic Acid for Prevention of Fractures in Patients with Parkinson's Disease
-
Supported High Intensity Fitness Training And Recreation
-
A Randomized, Double-blind, placebo-controlled, two-part study in Parkinson's disease patients with dyskinesia
-
A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, 27-WEEK TRIAL TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF TWO FIXED DOSES OF TAVAPADON IN EARLY PARKINSON’S DISEASE
-
A Phase 2, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical
-
A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease
-
Addex Pharma S.A. / “Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Dipraglurant (ADX48621) for the Treatment